ROBYN CAMPBELL: Open Payments
NPI 1740226810 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 37 payments from 16 companies in 2025. Trend: 2023 $572 · 2024 $591 · 2025 $734
Food & beverage: $734
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $188 |
| Lilly USA, LLC | 6 | $110 |
| Novo Nordisk Inc | 5 | $88 |
| Abbott Laboratories | 3 | $66 |
| Boston Scientific Corporation | 1 | $54 |
| PFIZER INC. | 2 | $41 |
| Dexcom, Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Organon LLC | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
Products named: BREZTRI, MOUNJARO, FREESTYLE LIBRE 3, AIRSUPRA, General - Pain Management, Ozempic, FARXIGA, JARDIANCE.
Industry payments across MO — which companies pay providers there.
